ILMN

$235.9918.64%-54.07

Nachbörslich: 236.54+0.55 +0.23%

Illumina Inc (ILMN)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$290.06

Offen:

$255.77

24-Stunden-Volumen:

5,385,149

Relatives Volumen:

2.45

Marktkapitalisierung:

$35.63B

Einnahmen:

$4.39B

Nettoeinkommen (Verlust:

$853.00M

KGV:

42.83

EPS:

$5.51

Netto-Cashflow:

$556.00M

1W Leistung:

-12.41%

1M Leistung:

-13.77%

6M Leistung:

+86.20%

1Y Leistung:

+138.35%

1-Tages-Spanne:

$231.18$256.09

1-Wochen-Bereich:

$231.18$294.21

52-Wochen-Spanne:

$94.00$309.35

Illumina Inc Aktie (ILMN) Unternehmensprofil

Firmenname

Illumina Inc

Sektor

Healthcare

Branche

Diagnostics & Research

Telefon

(858) 202-4500

Adresse

5200 ILLUMINA WAY, SAN DIEGO, CA, USA

Mitarbeiter

8,600

@illumina

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

ILMN-Diskussionen auf X

ILMN vs. TMO, DHR, NTRA, A, WAT vergleichen

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ILMN Illumina Inc	$235.99	$35.63B	$4.39B	$853.00M	$556.00M	$5.51
TMO Thermo Fisher Scientific Inc	$697.00	$257.71B	$45.20B	$6.87B	$6.75B	$18.19
DHR Danaher Corp	$232.23	$163.25B	$24.78B	$3.68B	$5.29B	$5.17
NTRA Natera Inc	$414.30	$59.72B	$2.50B	-$226.32M	$71.51M	-$1.64
A Agilent Technologies Inc	$174.87	$49.30B	$7.23B	$1.41B	$1.09B	$4.98
WAT Waters Corp	$462.72	$45.46B	$3.77B	$449.25M	$240.68M	$7.86

Illumina Inc Aktie (ILMN) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-10-23	Herabstufung	Stephens	Overweight → Equal-Weight
2026-09-09	Resumed	UBS	Buy
2026-06-26	Resumed	Bernstein	Mkt Perform
2026-06-10	Hochstufung	JP Morgan	Neutral → Overweight
2026-05-15	Resumed	RBC Capital Mkts	Outperform
2026-05-14	Hochstufung	Daiwa Securities	Neutral → Outperform
2025-08-12	Herabstufung	Daiwa Securities	Outperform → Neutral
2025-07-11	Herabstufung	Scotiabank	Sector Outperform → Sector Perform
2025-03-04	Bestätigt	Citigroup	Neutral
2025-02-28	Herabstufung	HSBC Securities	Buy → Hold
2025-02-10	Herabstufung	Barclays	Equal Weight → Underweight
2025-02-07	Herabstufung	TD Cowen	Buy → Hold
2024-12-11	Herabstufung	Citigroup	Buy → Neutral
2024-11-12	Resumed	Morgan Stanley	Equal-Weight
2024-10-17	Hochstufung	HSBC Securities	Hold → Buy
2024-08-28	Hochstufung	Argus	Hold → Buy
2024-08-16	Hochstufung	Daiwa Securities	Neutral → Buy
2024-08-14	Hochstufung	Barclays	Underweight → Equal Weight
2024-08-14	Hochstufung	TD Cowen	Hold → Buy
2024-07-10	Hochstufung	Citigroup	Neutral → Buy
2024-06-03	Resumed	Jefferies	Hold
2024-01-16	Herabstufung	HSBC Securities	Buy → Hold
2024-01-04	Herabstufung	TD Cowen	Outperform → Market Perform
2023-12-18	Hochstufung	Scotiabank	Sector Perform → Sector Outperform
2023-12-15	Hochstufung	Bernstein	Underperform → Mkt Perform
2023-12-14	Eingeleitet	Guggenheim	Buy
2023-12-14	Eingeleitet	Stephens	Overweight
2023-12-13	Eingeleitet	Wolfe Research	Outperform
2023-12-12	Herabstufung	BofA Securities	Neutral → Underperform
2023-12-11	Hochstufung	Citigroup	Sell → Neutral
2023-11-10	Herabstufung	Canaccord Genuity	Buy → Hold
2023-09-28	Eingeleitet	Bernstein	Underperform
2023-07-05	Resumed	JP Morgan	Neutral
2023-01-25	Herabstufung	Argus	Buy → Hold
2023-01-05	Eingeleitet	Scotiabank	Sector Perform
2022-12-12	Herabstufung	Citigroup	Neutral → Sell
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-10-04	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-09-28	Hochstufung	Evercore ISI	In-line → Outperform
2022-08-25	Eingeleitet	Credit Suisse	Neutral
2022-07-13	Herabstufung	Barclays	Equal Weight → Underweight
2022-01-18	Hochstufung	Stifel	Hold → Buy
2022-01-11	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-07	Hochstufung	BofA Securities	Underperform → Neutral
2022-01-06	Resumed	Morgan Stanley	Equal-Weight
2022-01-06	Resumed	Piper Sandler	Overweight
2021-10-15	Resumed	Cowen	Outperform
2021-08-19	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2021-06-01	Hochstufung	Evercore ISI	Underperform → In-line
2021-03-31	Herabstufung	Atlantic Equities	Overweight → Neutral
2021-03-31	Hochstufung	Canaccord Genuity	Hold → Buy
2021-03-03	Eingeleitet	Barclays	Underweight
2020-12-22	Hochstufung	Piper Sandler	Neutral → Overweight
2020-12-17	Hochstufung	BTIG Research	Neutral → Buy
2020-10-13	Herabstufung	Guggenheim	Buy → Neutral
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-09-29	Herabstufung	Wolfe Research	Outperform → Peer Perform
2020-09-22	Herabstufung	Stifel	Buy → Hold
2020-09-22	Herabstufung	UBS	Buy → Neutral
2020-09-21	Hochstufung	Guggenheim	Neutral → Buy
2020-09-21	Herabstufung	JP Morgan	Overweight → Neutral
2020-09-09	Eingeleitet	Morgan Stanley	Equal-Weight
2020-08-07	Herabstufung	Evercore ISI	In-line → Underperform
2020-08-07	Herabstufung	Piper Sandler	Overweight → Neutral
2020-07-07	Herabstufung	Guggenheim	Buy → Neutral
2020-04-24	Herabstufung	Citigroup	Buy → Neutral
2020-04-21	Herabstufung	Robert W. Baird	Outperform → Neutral
2020-01-08	Eingeleitet	Wells Fargo	Underweight
2020-01-07	Eingeleitet	Citigroup	Buy
2020-01-02	Herabstufung	Evercore ISI	Outperform → In-line
2019-11-15	Eingeleitet	Stifel	Buy
2019-10-25	Eingeleitet	Guggenheim	Buy

Finanzdaten der Illumina Inc-Aktie (ILMN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Illumina Inc-Aktie (ILMN) Insiderhandel

Corvex Management LPSep 04 '26
Affiliate of Director (1)
Transaktion
Proposed Sale
Kosten
$213.25
#Aktien
150,000
Wert ($)
31,987,500
#Aktien Gesamt
0
Meister Keith A.Sep 03 '26
Director
Transaktion
Sale
Kosten
$218.23
#Aktien
75,951
Wert ($)
16,574,481
#Aktien Gesamt
889,851
Meister Keith A.Sep 02 '26
Director
Transaktion
Sale
Kosten
$213.28
#Aktien
68,108
Wert ($)
14,526,254
#Aktien Gesamt
965,802
Corvex Management LPAug 27 '26
Affiliate of Director (1)
Transaktion
Proposed Sale
Kosten
$224.84
#Aktien
200,000
Wert ($)
44,968,000
#Aktien Gesamt
0
Meister Keith A.Aug 27 '26
Director
Transaktion
Sale
Kosten
$228.89
#Aktien
138,379
Wert ($)
31,673,778
#Aktien Gesamt
1,033,910
Meister Keith A.Aug 26 '26
Director
Transaktion
Sale
Kosten
$225.46
#Aktien
106,543
Wert ($)
24,021,247
#Aktien Gesamt
1,172,289
Corvex Management LPAug 25 '26
Affiliate of Director (1)
Transaktion
Proposed Sale
Kosten
$223.22
#Aktien
300,000
Wert ($)
66,966,000
#Aktien Gesamt
0
Meister Keith A.Aug 25 '26
Director
Transaktion
Sale
Kosten
$225.51
#Aktien
131,019
Wert ($)
29,546,639
#Aktien Gesamt
1,278,832
Meister Keith A.Aug 21 '26
Director
Transaktion
Sale
Kosten
$217.96
#Aktien
299,336
Wert ($)
65,243,445
#Aktien Gesamt
1,409,851
Corvex Management LPAug 21 '26
Affiliate of Director (1)
Transaktion
Proposed Sale
Kosten
$213.24
#Aktien
250,000
Wert ($)
53,310,000
#Aktien Gesamt
0

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Corvex Management LP	Affiliate of Director (1)	Sep 04 '26	Proposed Sale	$213.25	150,000	31,987,500	0
Meister Keith A.	Director	Sep 03 '26	Sale	$218.23	75,951	16,574,481	889,851
Meister Keith A.	Director	Sep 02 '26	Sale	$213.28	68,108	14,526,254	965,802
Corvex Management LP	Affiliate of Director (1)	Aug 27 '26	Proposed Sale	$224.84	200,000	44,968,000	0
Meister Keith A.	Director	Aug 27 '26	Sale	$228.89	138,379	31,673,778	1,033,910
Meister Keith A.	Director	Aug 26 '26	Sale	$225.46	106,543	24,021,247	1,172,289
Corvex Management LP	Affiliate of Director (1)	Aug 25 '26	Proposed Sale	$223.22	300,000	66,966,000	0
Meister Keith A.	Director	Aug 25 '26	Sale	$225.51	131,019	29,546,639	1,278,832
Meister Keith A.	Director	Aug 21 '26	Sale	$217.96	299,336	65,243,445	1,409,851
Corvex Management LP	Affiliate of Director (1)	Aug 21 '26	Proposed Sale	$213.24	250,000	53,310,000	0

Illumina Inc Aktie (ILMN) Neueste Nachrichten

Oct 30, 2026

ILMN Q3 Earnings Call Highlights Higher Guidance and Clinical Growth - Zacks Investment Research

Oct 30, 2026

Why is Illumina stock tumbling today? - Investing.com

Oct 30, 2026

Oct 29, 2026